Back to Results

A Phase 3, Open-label, Multi-center, Single Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel (MK-8415) Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger

Study

Is this Study for You?

Let's Get Started!

Description

? 11 visits over 27 months ? Physical Exam, Pelvic Exam, Pap smear (if needed), STI screening ? Blood draws ? Daily e-diary completion

Details
Age

Adult

Eligibility

? Age: 18-35 years ? Sexually Active ? Must have a palpable implant in place (for at least 2 years, no longer than 3 years by the time of enrollment)

Phase

III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.

Type of Study

Device Feasibility

Location

Comprehensive Women's Health Center

Principal Investigator
Rebecca Cohen,  MD

Rebecca Cohen, MD

Study ID

Protocol Number: 20-2734

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers